These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 11804028

  • 1. Evidence that the rat osteopetrotic mutation toothless (tl) is not in the TNFSF11 (TRANCE, RANKL, ODF, OPGL) gene.
    Odgren PR, Kim N, van Wesenbeeck L, MacKay C, Mason-Savas A, Safadi FF, Popoff SN, Lengner C, van-Hul W, Choi Y, Marks SC.
    Int J Dev Biol; 2001 Dec; 45(8):853-9. PubMed ID: 11804028
    [Abstract] [Full Text] [Related]

  • 2. The role of RANKL (TRANCE/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue.
    Odgren PR, Kim N, MacKay CA, Mason-Savas A, Choi Y, Marks SC.
    Connect Tissue Res; 2003 Dec; 44 Suppl 1():264-71. PubMed ID: 12952207
    [Abstract] [Full Text] [Related]

  • 3. Perspective. Osteoclastogenesis and growth plate chondrocyte differentiation: emergence of convergence.
    Odgren PR, Philbrick WM, Gartland A.
    Crit Rev Eukaryot Gene Expr; 2003 Dec; 13(2-4):181-93. PubMed ID: 14696966
    [Abstract] [Full Text] [Related]

  • 4. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [Abstract] [Full Text] [Related]

  • 5. Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank.
    Kapur RP, Yao Z, Iida MH, Clarke CM, Doggett B, Xing L, Boyce BF.
    J Bone Miner Res; 2004 Oct; 19(10):1689-97. PubMed ID: 15355564
    [Abstract] [Full Text] [Related]

  • 6. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.
    Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM.
    Nature; 1999 Jan 28; 397(6717):315-23. PubMed ID: 9950424
    [Abstract] [Full Text] [Related]

  • 7. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
    Sordillo EM, Pearse RN.
    Cancer; 2003 Feb 01; 97(3 Suppl):802-12. PubMed ID: 12548579
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of colony stimulating factor-1 gene expression in the skeleton of four osteopetrotic mutations in rats and mice.
    Shalhoub V, Jackson ME, Paradise C, Stein GS, Lian JB, Marks SC.
    J Cell Physiol; 1996 Feb 01; 166(2):340-50. PubMed ID: 8591994
    [Abstract] [Full Text] [Related]

  • 9. Regulation of the differentiation and function of osteoclasts.
    Chambers TJ.
    J Pathol; 2000 Sep 01; 192(1):4-13. PubMed ID: 10951393
    [Abstract] [Full Text] [Related]

  • 10. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.
    J Cell Physiol; 2005 Jun 01; 203(3):573-82. PubMed ID: 15573398
    [Abstract] [Full Text] [Related]

  • 11. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH.
    Free Radic Biol Med; 2006 May 01; 40(9):1483-93. PubMed ID: 16632109
    [Abstract] [Full Text] [Related]

  • 12. Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways.
    Takami M, Cho ES, Lee SY, Kamijo R, Yim M.
    FEBS Lett; 2005 Jan 31; 579(3):832-8. PubMed ID: 15670856
    [Abstract] [Full Text] [Related]

  • 13. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
    Blin-Wakkach C, Breuil V, Quincey D, Bagnis C, Carle GF.
    Bone; 2006 Jul 31; 39(1):53-60. PubMed ID: 16503212
    [Abstract] [Full Text] [Related]

  • 14. Colony-stimulating factor-1 (CSF-1) rescues osteoblast attachment, survival and sorting of beta-actin mRNA in the toothless (tl-osteopetrotic) mutation in the rat.
    Watanabe H, MacKay CA, Mason-Savas A, Kislauskis EH, Marks SC.
    Int J Dev Biol; 2000 Feb 31; 44(2):201-7. PubMed ID: 10794078
    [Abstract] [Full Text] [Related]

  • 15. Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis.
    Mizuno A, Kanno T, Hoshi M, Shibata O, Yano K, Fujise N, Kinosaki M, Yamaguchi K, Tsuda E, Murakami A, Yasuda H, Higashio K.
    J Bone Miner Metab; 2002 Feb 31; 20(6):337-44. PubMed ID: 12434161
    [Abstract] [Full Text] [Related]

  • 16. Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL.
    Kawaida R, Ohtsuka T, Okutsu J, Takahashi T, Kadono Y, Oda H, Hikita A, Nakamura K, Tanaka S, Furukawa H.
    J Exp Med; 2003 Apr 21; 197(8):1029-35. PubMed ID: 12707301
    [Abstract] [Full Text] [Related]

  • 17. TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis.
    Abu-Amer Y, Abbas S, Hirayama T.
    J Cell Biochem; 2004 Nov 15; 93(5):980-9. PubMed ID: 15389885
    [Abstract] [Full Text] [Related]

  • 18. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene.
    Kim N, Odgren PR, Kim DK, Marks SC, Choi Y.
    Proc Natl Acad Sci U S A; 2000 Sep 26; 97(20):10905-10. PubMed ID: 10984520
    [Abstract] [Full Text] [Related]

  • 19. Mutation of macrophage colony stimulating factor (Csf1) causes osteopetrosis in the tl rat.
    Dobbins DE, Sood R, Hashiramoto A, Hansen CT, Wilder RL, Remmers EF.
    Biochem Biophys Res Commun; 2002 Jun 28; 294(5):1114-20. PubMed ID: 12074592
    [Abstract] [Full Text] [Related]

  • 20. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K.
    J Cell Physiol; 2004 Oct 28; 201(1):17-25. PubMed ID: 15281085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.